These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38356181)

  • 21. Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.
    Koenig P; Lee CV; Sanowar S; Wu P; Stinson J; Harris SF; Fuh G
    J Biol Chem; 2015 Sep; 290(36):21773-86. PubMed ID: 26088137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications.
    Goydel RS; Weber J; Peng H; Qi J; Soden J; Freeth J; Park H; Rader C
    J Biol Chem; 2020 May; 295(18):5995-6006. PubMed ID: 32193207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five computational developability guidelines for therapeutic antibody profiling.
    Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.
    Adler AS; Mizrahi RA; Spindler MJ; Adams MS; Asensio MA; Edgar RC; Leong J; Leong R; Johnson DS
    MAbs; 2017; 9(8):1270-1281. PubMed ID: 28846506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting antibody binders and generating synthetic antibodies using deep learning.
    Lim YW; Adler AS; Johnson DS
    MAbs; 2022; 14(1):2069075. PubMed ID: 35482911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
    Makowski EK; Chen H; Lambert M; Bennett EM; Eschmann NS; Zhang Y; Zupancic JM; Desai AA; Smith MD; Lou W; Fernando A; Tully T; Gallo CJ; Lin L; Tessier PM
    MAbs; 2022; 14(1):2146629. PubMed ID: 36433737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VH-VL orientation prediction for antibody humanization candidate selection: A case study.
    Bujotzek A; Lipsmeier F; Harris SF; Benz J; Kuglstatter A; Georges G
    MAbs; 2016; 8(2):288-305. PubMed ID: 26637054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody humanization-the Influence of the antibody framework on the CDR-H3 loop ensemble in solution.
    Fernández-Quintero ML; Heiss MC; Liedl KR
    Protein Eng Des Sel; 2019 Dec; 32(9):411-422. PubMed ID: 32129452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coevolved Canonical Loops Conformations of Single-Domain Antibodies: A Tale of Three Pockets Playing Musical Chairs.
    Gaudreault F; Corbeil CR; Purisima EO; Sulea T
    Front Immunol; 2022; 13():884132. PubMed ID: 35720356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A library approach for the
    Arras P; Yoo HB; Pekar L; Schröter C; Clarke T; Krah S; Klewinghaus D; Siegmund V; Evers A; Zielonka S
    MAbs; 2023; 15(1):2261149. PubMed ID: 37766540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye.
    Tesar D; Luoma J; Wyatt EA; Shi C; Shatz W; Hass PE; Mathieu M; Yi L; Corn JE; Maass KF; Wang K; Dion MZ; Andersen N; Loyet KM; van Lookeren Campagne M; Rajagopal K; Dickmann L; Scheer JM; Kelley RF
    MAbs; 2017; 9(8):1297-1305. PubMed ID: 28854082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41.
    Mader A; Kunert R
    Protein Eng Des Sel; 2010 Dec; 23(12):947-54. PubMed ID: 21037278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.
    Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y
    J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
    Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
    J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallucinating structure-conditioned antibody libraries for target-specific binders.
    Mahajan SP; Ruffolo JA; Frick R; Gray JJ
    Front Immunol; 2022; 13():999034. PubMed ID: 36341416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural diversity in a human antibody germline library.
    Teplyakov A; Obmolova G; Malia TJ; Luo J; Muzammil S; Sweet R; Almagro JC; Gilliland GL
    MAbs; 2016; 8(6):1045-63. PubMed ID: 27210805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into humanization of anti-tissue factor antibody 10H10.
    Teplyakov A; Obmolova G; Malia TJ; Raghunathan G; Martinez C; Fransson J; Edwards W; Connor J; Husovsky M; Beck H; Chi E; Fenton S; Zhou H; Almagro JC; Gilliland GL
    MAbs; 2018; 10(2):269-277. PubMed ID: 29283291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.